Phosphoinositide 3-kinase in health and disease Volume 2
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , , |
| التنسيق: | Electronic Resource |
| اللغة: | English |
| منشور في: |
Berlin, Heidelberg
Springer
2011.
|
| سلاسل: | Current Topics in Microbiology and Immunology
347 |
| الموضوعات: | |
| الوصول للمادة أونلاين: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |


